MiR-142-5p strengthens cell growth and migration in renal cell carcinoma, while miR-93 desensitizes esophageal cancer to radiotherapy by targeting BTG3 (Cui et al., 2017; Liu et al., 2017). This evidence concerns the gene BTG3 and hereditary clear cell renal cell carcinoma.